These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 21331754)

  • 1. Soluble CD40 ligand and prolactin levels in migraine patients during interictal period.
    Guldiken S; Guldiken B; Demir M; Kabayel L; Ozkan H; Turgut N; Hunkar R; Kat S
    J Headache Pain; 2011 Jun; 12(3):355-60. PubMed ID: 21331754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The levels of circulating markers of atherosclerosis and inflammation in subjects with different degrees of body mass index: Soluble CD40 ligand and high-sensitivity C-reactive protein.
    Guldiken S; Demir M; Arikan E; Turgut B; Azcan S; Gerenli M; Tugrul A
    Thromb Res; 2007; 119(1):79-84. PubMed ID: 16476470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced levels of soluble CD40 ligand and C-reactive protein in a total of 312 patients with metabolic syndrome.
    Unek IT; Bayraktar F; Solmaz D; Ellidokuz H; Yuksel F; Sisman AR; Yesil S
    Metabolism; 2010 Mar; 59(3):305-13. PubMed ID: 20006362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The alteration of serum soluble CD40 ligand levels in overt and subclinical hypothyroidism.
    Akinci B; Comlekci A; Yener S; Demir T; Bayraktar F; Yuksel F; Yesil S
    Hormones (Athens); 2007; 6(4):327-33. PubMed ID: 18055424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble CD40 ligand and soluble P-selectin levels in Gilbert's syndrome: a link to protection against atherosclerosis?
    Tapan S; Dogru T; Tasci I; Ercin CN; Ozgurtas T; Erbil MK
    Clin Biochem; 2009 Jun; 42(9):791-5. PubMed ID: 19232335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soluble CD40 ligand levels in otherwise healthy subjects with impaired fasting glucose.
    Tasci I; Dogru T; Sonmez A; Genc H; Kilic S; Olgun A; Gok M; Erdem G; Erikci S
    Mediators Inflamm; 2006; 2006(5):32508. PubMed ID: 17392573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of simvastatin, losartan, and combined therapy on soluble CD40 ligand in hypercholesterolemic, hypertensive patients.
    Han SH; Koh KK; Quon MJ; Lee Y; Shin EK
    Atherosclerosis; 2007 Jan; 190(1):205-11. PubMed ID: 16500662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The levels of soluble CD40 ligand and C-reactive protein in normal weight, overweight and obese people.
    Unek IT; Bayraktar F; Solmaz D; Ellidokuz H; Sisman AR; Yuksel F; Yesil S
    Clin Med Res; 2010 Jul; 8(2):89-95. PubMed ID: 20660932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atherosclerosis risk factors in children of parents with the metabolic syndrome.
    Akinci G; Coskun S; Akinci B; Hekimsoy Z; Bayindir P; Onur E; Ozmen B
    Atherosclerosis; 2007 Oct; 194(2):e165-71. PubMed ID: 17210154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of continuous positive airway pressure on soluble CD40 ligand in patients with obstructive sleep apnea syndrome.
    Kobayashi K; Nishimura Y; Shimada T; Yoshimura S; Funada Y; Satouchi M; Yokoyama M
    Chest; 2006 Mar; 129(3):632-7. PubMed ID: 16537861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diverse associations of microalbuminuria with C-reactive protein, interleukin-18 and soluble CD 40 ligand in male essential hypertensive subjects.
    Tsioufis C; Dimitriadis K; Taxiarchou E; Vasiliadou C; Chartzoulakis G; Tousoulis D; Manolis A; Stefanadis C; Kallikazaros I
    Am J Hypertens; 2006 May; 19(5):462-6. PubMed ID: 16647614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associations between soluble CD40 ligand, atherosclerosis risk factors, and subclinical atherosclerosis: results from the Dallas Heart Study.
    de Lemos JA; Zirlik A; Schönbeck U; Varo N; Murphy SA; Khera A; McGuire DK; Stanek G; Lo HS; Nuzzo R; Morrow DA; Peshock R; Libby P
    Arterioscler Thromb Vasc Biol; 2005 Oct; 25(10):2192-6. PubMed ID: 16109925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble CD40 ligand, high sensitive C-reactive protein and fetuin-A levels in patients with essential thrombocythemia.
    Bilgir F; Bilgir O; Kebapcilar L; Calan M; Ozdemirkiran F; Cinali T; Bozkaya G
    Transfus Apher Sci; 2012 Feb; 46(1):67-71. PubMed ID: 22196954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble CD40 ligand levels in patients with hypertension.
    Sonmez A; Dogru T; Yilmaz MI; Ocal R; Ozgurtas T; Kilic S; Eyileten T; Tasci I; Erbil K; Kocar IH
    Clin Exp Hypertens; 2005 Nov; 27(8):629-34. PubMed ID: 16303639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Levels of soluble CD40 ligand and P-Selectin in nonalcoholic fatty liver disease.
    Ercin CN; Dogru T; Tapan S; Karslioglu Y; Haymana C; Kilic S; Sonmez A; Yesilova Z; Uygun A; Gulsen M; Bagci S; Kemal Erbil M
    Dig Dis Sci; 2010 Apr; 55(4):1128-34. PubMed ID: 19440836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcoronary concentration gradient of sCD40L and hsCRP in patients with coronary heart disease.
    Wang Y; Li L; Tan HW; Yu GS; Ma ZY; Zhao YX; Zhang Y
    Clin Cardiol; 2007 Feb; 30(2):86-91. PubMed ID: 17326063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New pathways of increased cardiovascular risk in depression: a pilot study on the association of high-sensitivity C-reactive protein with pro-atherosclerotic markers in patients with depression.
    Zahn D; Petrak F; Uhl I; Juckel G; Neubauer H; Hägele AK; Wiltfang J; Herpertz S
    J Affect Disord; 2013 Apr; 146(3):420-5. PubMed ID: 22999070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Men with lower HDL cholesterol levels have significant increment of soluble CD40 ligand and high-sensitivity CRP levels following the cessation of long-term clopidogrel therapy.
    Obradovic S; Djukanovic N; Todorovic Z; Markovic I; Zamaklar-Trifunovic D; Protic D; Ostojic M
    J Atheroscler Thromb; 2015; 22(3):284-92. PubMed ID: 25273829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atorvastatin decreases elevated soluble CD40L in subjects at high cardiovascular risk. Atorvastatin on inflammatory markers study: a substudy of ACTFAST.
    Blanco-Colio LM; Martín-Ventura JL; de Teresa E; Farsang C; Gaw A; Gensini G; Leiter LA; Langer A; Martineau P; Egido J;
    Kidney Int Suppl; 2008 Dec; (111):S60-3. PubMed ID: 19034329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble CD40 ligand, platelet surface CD40 ligand, and total platelet CD40 ligand in atrial fibrillation: relationship to soluble P-selectin, stroke risk factors, and risk factor intervention.
    Choudhury A; Chung I; Panja N; Patel J; Lip GYH
    Chest; 2008 Sep; 134(3):574-581. PubMed ID: 18641098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.